person

Mikael Kjaer P.

Country
Denmark
Department
Cardiology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 1 partner site.

Specializations

Atherosclerotic Cardiovascular Disease

The investigator focuses on the prevention and management of atherosclerotic cardiovascular disease and its risk factors.

  • Primary prevention in high‑risk patients
  • Lipid‑lowering strategies
  • Inflammation‑targeted therapies

Research includes patients with elevated lipoprotein(a) and co‑existing metabolic disorders.

Heart Failure

Clinical work addresses both reduced and preserved ejection fraction heart failure, emphasizing disease progression and therapeutic optimization.

  • HFrEF with guideline‑directed medical therapy
  • HFpEF associated with obesity and systemic inflammation
  • Biomarker‑driven treatment pathways

Investigations often involve acute decompensation and long‑term outcomes.

Arrhythmias and Cardiac Rhythm Disorders

Efforts are concentrated on atrial and ventricular arrhythmias, particularly in peri‑operative and acute care settings.

  • Atrial fibrillation after non‑cardiac surgery
  • Post‑myocardial infarction ventricular tachyarrhythmias
  • Device‑based rhythm management

Studies evaluate stroke prevention, anticoagulation strategies, and rhythm control efficacy.

Cardiac Amyloidosis and Infiltrative Cardiomyopathies

The investigator explores treatment approaches for patients with amyloid deposition affecting cardiac structure and function.

  • Transthyretin amyloid cardiomyopathy (ATTR‑CM)
  • Light‑chain (AL) amyloidosis with cardiac involvement
  • Novel agents targeting amyloid stabilization

Outcomes focus on functional capacity, biomarker trends, and survival.

Acute Coronary Syndromes and Myocardial Infarction

Research targets early intervention and secondary prevention following acute coronary events.

  • ST‑elevation myocardial infarction (STEMI) management
  • Non‑ST‑elevation acute coronary syndrome pathways
  • Post‑revascularization antithrombotic regimens

Emphasis is placed on reducing major adverse cardiovascular events and rehospitalization.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.